bpc 157 research human safety BPC-157 – No Proof Required! | Office for Science and Society If BPC-157 worked as well
Description
The listings were just removed
TB-500 bioavailability follows similar patterns, though its larger molecular size may result in slightly lower nasal absorption compared to BPC-157
2 Additionally, among those with EGFR- mutant disease, the confirmed ORR was 43.6%, with a disease control rate (DCR) of 82.1% and a median DOR of 7.0 months
While these findings established BPC-157 as a novel cytoprotective agent, its use in humans remains investigational and unapproved by regulatory bodies
More DPCs means a stronger, more sustained growth signal
